SCR-LIP-000446 · Claim · machine-readable JSON →
A narrative review estimates lipedema prevalence at ~12.3% of the Brazilian female population (~8.8 million women), reports an affected first-degree relative in up to 60% of patients with an autosomal dominant sex-limited inheritance pattern, and notes common comorbidities of hypertension, anemia, anxiety, and depression.
This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- very low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 0 question(s)
- Dates
- 2026-11-17 → 2026-11-17
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17
Evidence over time
Evidence (1)
- Lipedema: pathophysiological insights and therapeutic strategies — An update for dermatologists (2026) ✓ verified — consistent · review · 2026 · reading confidence: high
“Estimated Brazilian prevalence: ~12.3% of female population (~8.8 million women), commonly comorbid with hypertension, anemia, anxiety, and depression Genetic basis: up to 60% of patients have an affected first-degree relative; autosomal dominant pattern with sex-limited incomplete penetrance”
The review directly reports prevalence (~12.3% of women) and who is affected (female, familial clustering up to 60%, autosomal dominant sex-limited penetrance), bearing affirmatively on how common lipedema is and who it affects, though esti
Context (PECO)
Answers these questions
- Not yet linked to a question.
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-11-17 — created · auto-ingested for SQ-LIP-000002
- 2026-11-20 — consolidated · SQ-LIP-000002: evidence moved to SCR-LIP-000593